Form 4 for ZVRA ZEVRA THERAPEUTICS, INC.
Accepted 2021-11-23 00:00:00 ET · period of report 2021-11-18 · accession 0001437749-21-027301 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-11-23 | 2021-11-18 | ZVRA | Mickle Travis C | Pres, CEO, Dir | P - Purchase | $8.23 | +2,250 | 36.5K | +7% | +$18.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-18 | P | A | 2,250 | $8.23 | 36,521 | D | — | — |